TickerFacts.

Compare

Viridian Therapeutics, Inc. vs Assembly Biosciences, Inc. vs Rockwell Medical, Inc. vs Bicycle Therapeutics PLC

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearViridian Therapeutics, Inc.
VRDN		Assembly Biosciences, Inc.
ASMB		Rockwell Medical, Inc.
RMTI		Bicycle Therapeutics PLC
BCYC
Year ended2025-12-312025-12-312025-12-312025-12-31
Revenue$70.85M$72.30M$69.26M$72.59M
Revenue growth (YoY)n/m+153.5%-31.8%+105.8%
Gross marginn/an/a16.9%n/a
Operating margin-512.9%-16.8%-6.8%-340.4%
Net margin-483.6%-8.5%-7.7%-301.7%
Net income-$342.60M-$6.12M-$5.31M-$218.96M
EPS (Diluted)n/a-$0.55-$0.15-$3.16
Operating cash flow-$276.39M-$41.09M-$659.0K-$249.68M
Free cash flow-$276.89M-$41.16M-$1.20M-$252.03M
Cash & equivalentsn/a$58.45M$10.71M$628.11M
Total assets$899.42M$257.59M$57.15M$717.60M
Total liabilities$177.25M$50.84M$20.16M$107.62M
Shareholders' equity$722.17M$206.75M$36.98M$609.98M
Return on year-end equity-47.4%-3.0%-14.4%-35.9%
Shares outstanding101.83M15.86M39.41M69.37M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearViridian Therapeutics, Inc.Assembly Biosciences, Inc.Rockwell Medical, Inc.Bicycle Therapeutics PLC
Latest$70.85M
Ended 2025-12-31		$72.30M
Ended 2025-12-31		$69.26M
Ended 2025-12-31		$72.59M
Ended 2025-12-31
1 year earlier$302.0K
Ended 2024-12-31		$28.52M
Ended 2024-12-31		$101.49M
Ended 2024-12-31		$35.27M
Ended 2024-12-31
2 years earlier$314.0K
Ended 2023-12-31		$7.16M
Ended 2023-12-31		$83.61M
Ended 2023-12-31		$26.98M
Ended 2023-12-31
3 years earlier$1.77M
Ended 2022-12-31		$0
Ended 2022-12-31		$72.81M
Ended 2022-12-31		$14.46M
Ended 2022-12-31
4 years earlier$2.96M
Ended 2021-12-31		$6.25M
Ended 2021-12-31		$61.93M
Ended 2021-12-31		$11.70M
Ended 2021-12-31